2021
DOI: 10.1016/j.cancergen.2021.10.005
|View full text |Cite
|
Sign up to set email alerts
|

The oncogenic roles of NTRK fusions and methods of molecular diagnosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 96 publications
0
2
0
Order By: Relevance
“…The neurotrophic tropomyosin receptor kinases (TrK) are a family of transmembrane tyrosine kinases that are important players in neural development 9 . TrK family consists of three transmembrane neurotrophin receptors TrkA, TrkB, and TrkC which are encoded by NTRK1 , NTRK2 , and NTRK3 , respectively 10 . Although representing less than 5% of all human malignancies, NTRK fusion has been well described in a wide variety of tumors, including secretory breast carcinoma, congenital mesoblastic nephroma, and NTRK‐rearranged spindle cell mesenchymal tumors 11,12 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The neurotrophic tropomyosin receptor kinases (TrK) are a family of transmembrane tyrosine kinases that are important players in neural development 9 . TrK family consists of three transmembrane neurotrophin receptors TrkA, TrkB, and TrkC which are encoded by NTRK1 , NTRK2 , and NTRK3 , respectively 10 . Although representing less than 5% of all human malignancies, NTRK fusion has been well described in a wide variety of tumors, including secretory breast carcinoma, congenital mesoblastic nephroma, and NTRK‐rearranged spindle cell mesenchymal tumors 11,12 .…”
Section: Discussionmentioning
confidence: 99%
“…9 TrK family consists of three transmembrane neurotrophin receptors TrkA, TrkB, and TrkC which are encoded by NTRK1, NTRK2, and NTRK3, respectively. 10 Although representing less than 5% of all human malignancies, NTRK fusion has been well described in a wide variety of tumors, including secretory breast carcinoma, congenital mesoblastic nephroma, and NTRK-rearranged spindle cell mesenchymal tumors. 11,12 Recognition of NTRK fusion-positive malignancies is important not only for diagnostic purpose, but also for targeted therapy in selected patients.…”
Section: Discussionmentioning
confidence: 99%